Latest news with #MedicoRemedies
Mint
7 hours ago
- Business
- Mint
Stocks to buy under ₹100: Experts recommend four shares to buy today — 18 June 2025
Stocks to buy under ₹ 100: After rising for two straight sessions, the Indian stock market paused and finished lower on Tuesday. The Nifty 50 index ended 92 points lower at 24,853, the BSE Sensex finished 212 points lower at 81,583, while the Bank Nifty index lost 230 points and closed at 55,714. The Nifty Mid-cap and the Nifty Small-cap Indices underperformed the benchmark, where the Nifty Mid-cap 100 Index fell by 0.66%, while the Nifty Small-cap 100 Index corrected by 0.69%. Market breadth remained weak for the fourth consecutive day, with declining stocks outpacing advancing ones, as indicated by a BSE advance-decline ratio of 0.60. Sectorally, it was a sea of red, except for the Nifty IT sector, which managed to stay in positive territory. The Nifty Pharma, Healthcare, Metal, and Consumer Durables indices were among the major losers. The Nifty Pharma Index took a hit, falling nearly 2% following warnings from US President Donald Trump about imminent tariffs on pharmaceutical imports. Speaking on the outlook of the Nifty 50 today, Shiju Kuthupalakkal, Senior Manager of Technical Research at Prabhudas Lilladher, said, "The Nifty 50 index, after witnessing a significant pullback in the last two sessions, found resistance near the 25,000 zone and with profit booking seen witnessed a gradual slide to end near the 24,850 level with bias and sentiment maintained with a cautious approach as of now. As mentioned earlier, the index would have the crucial support zone near the 24,500 zones and would need a decisive move above the 25,200 level to trigger a fresh further rise in the coming days." "The Bank Nifty index succumbed to profit booking during the session and slipped as the day progressed to close near the 55700 level, once again finding resistance near the 56000 zone, a crucial resistance zone. The index has been precariously placed and would need a decisive move above the 56000 zone to turn the bias positive. At the same time, we would need to sustain the near-term support positioned near the 55000 level to maintain the overall trend intact," Shiju Kuthupalakkal of Prabhudas Lilladher said. Regarding intraday stocks for today, market experts — Vaishali Parekh, Vice President of Technical Research at Prabhudas Lilladher; Anshul Jain, Head of Research at Lakshmishree Investment and Securities; and Mahesh M Ojha, AVP — Research at Hensex Securities — recommended buying these three stocks: Medico Remedies, Imagicaaworld Entertainment, Manali Petrochemicals, and Balmer Lawrie Investments. 1] Medico Remedies: Buy at ₹ 48.50, Target ₹ 53, Stop Loss ₹ 46. 2] Balmer Lawrie Investments: Buy at ₹ 80 to ₹ 81, Targets ₹ 83.50, ₹ 85, ₹ 88, ₹ 90, Stop Loss ₹ 78; and 3] Manali Petrochemicals: Buy at ₹ 64.25 to ₹ 65.25, Targets ₹ 67, ₹ 69, ₹ 71, ₹ 74, Stop Loss ₹ 62.80. 4] Imagicaaworld Entertainment: Buy at ₹ 68.40, Target ₹ 71.50, Stop Loss ₹ 67.
Mint
10 hours ago
- Business
- Mint
Stocks to buy under ₹100: Experts recommend four shares to buy today — 18 June 2025
Stocks to buy under ₹ 100: After rising for two straight sessions, the Indian stock market paused and finished lower on Tuesday. The Nifty 50 index ended 92 points lower at 24,853, the BSE Sensex finished 212 points lower at 81,583, while the Bank Nifty index lost 230 points and closed at 55,714. The Nifty Mid-cap and the Nifty Small-cap Indices underperformed the benchmark, where the Nifty Mid-cap 100 Index fell by 0.66%, while the Nifty Small-cap 100 Index corrected by 0.69%. Market breadth remained weak for the fourth consecutive day, with declining stocks outpacing advancing ones, as indicated by a BSE advance-decline ratio of 0.60. Sectorally, it was a sea of red, except for the Nifty IT sector, which managed to stay in positive territory. The Nifty Pharma, Healthcare, Metal, and Consumer Durables indices were among the major losers. The Nifty Pharma Index took a hit, falling nearly 2% following warnings from US President Donald Trump about imminent tariffs on pharmaceutical imports. Speaking on the outlook of the Nifty 50 today, Shiju Kuthupalakkal, Senior Manager of Technical Research at Prabhudas Lilladher, said, "The Nifty 50 index, after witnessing a significant pullback in the last two sessions, found resistance near the 25,000 zone and with profit booking seen witnessed a gradual slide to end near the 24,850 level with bias and sentiment maintained with a cautious approach as of now. As mentioned earlier, the index would have the crucial support zone near the 24,500 zones and would need a decisive move above the 25,200 level to trigger a fresh further rise in the coming days." "The Bank Nifty index succumbed to profit booking during the session and slipped as the day progressed to close near the 55700 level, once again finding resistance near the 56000 zone, a crucial resistance zone. The index has been precariously placed and would need a decisive move above the 56000 zone to turn the bias positive. At the same time, we would need to sustain the near-term support positioned near the 55000 level to maintain the overall trend intact," Shiju Kuthupalakkal of Prabhudas Lilladher said. Regarding intraday stocks for today, market experts — Vaishali Parekh, Vice President of Technical Research at Prabhudas Lilladher; Anshul Jain, Head of Research at Lakshmishree Investment and Securities; and Mahesh M Ojha, AVP — Research at Hensex Securities — recommended buying these three stocks: Medico Remedies, Imagicaaworld Entertainment, and Balmer Lawrie Investments. 1] Medico Remedies: Buy at ₹ 48.50, Target ₹ 53, Stop Loss ₹ 46. 2] Balmer Lawrie Investments: Buy at ₹ 80 to ₹ 81, Targets ₹ 83.50, ₹ 85, ₹ 88, ₹ 90, Stop Loss ₹ 78. 3] Imagicaaworld Entertainment: Buy at ₹ 68.40, Target ₹ 71.50, Stop Loss ₹ 67. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Business Standard
09-05-2025
- Business
- Business Standard
Medico Remedies standalone net profit rises 40.00% in the March 2025 quarter
Sales decline 0.05% to Rs 41.30 crore Net profit of Medico Remedies rose 40.00% to Rs 4.34 crore in the quarter ended March 2025 as against Rs 3.10 crore during the previous quarter ended March 2024. Sales declined 0.05% to Rs 41.30 crore in the quarter ended March 2025 as against Rs 41.32 crore during the previous quarter ended March 2024. For the full year,net profit rose 21.71% to Rs 10.09 crore in the year ended March 2025 as against Rs 8.29 crore during the previous year ended March 2024. Sales rose 4.15% to Rs 150.94 crore in the year ended March 2025 as against Rs 144.92 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 41.3041.32 0 150.94144.92 4 OPM % 16.1511.25 - 9.948.91 - PBDT 6.474.98 30 16.5314.22 16 PBT 5.704.24 34 13.5011.34 19 NP 4.343.10 40 10.098.29 22
